Abstract:Obesity has been recognized as a worldwide pandemic, and the first-line treatment is weight loss via a calorie restricted diet (1). Obstructive sleep apnea (OSA) is recognized as one of the key obesity-related comorbidities and has complex interactions with obesity and weight loss treatments. Treating OSA with continuous positive airway pressure (CPAP) is recommended widely in clinical practice as an adjunct therapy with weight loss despite a lack of evidence to support the strategy. Therefore, we conducted a retrospective study with the patients seen in UAMS weight loss clinic from 1/1/2014 to 8/31/2017. Patients were eligible if they were 18-65 years old, body mass index >= 30 and < 50, and underwent a 16-week intensive calorie restriction weight loss program obtained by strict calorie restriction (800 Kcal per day), exercise programs, weekly individual counseling and cognitive behavioral therapy. Patients who suffered from thyroid dysfunction, uncontrolled diabetes, active infection, active malignancy, or end-organ damage were excluded. Participants underwent a standardized medical examination before and every week in the program. Of the 300 patients included in the analysis, the average ages was 55 ± 10 years old, and 236 (78.7%) were female. They were divided into three groups based on self- reported OSA symptoms and CPAP treatment status: asymptomatic OSA group (OSA-A, n = 89), symptomatic group (OSA-S, n = 164), and OSA on CPAP treatment group (OSA-T, n = 47). In 16 weeks, the absolute weight loss of the OSA-T group was significantly higher than that of the OSA-S and OSA-A groups (-12.1 ± 5.9 vs. -9.5 ± 5.5 vs. -8.7 ± 5.3 kg, P < 0.01), whereas, the percentage weight loss of the OSA-T group was not significantly higher than that of the OSA-A and OSA-S groups (-10.46 ± 5.63% vs. -9.14 ± 4.89% vs. -8.47 ± 4.97%, P = 0.065). There had no difference of the absolute weight loss between OSA-A group and OSA-S group. Further analysis established a correlation of CPAP treatment to the absolute weight loss (Spearman’s correlation coefficient -0.181, P = 0.013) after adjustment of baseline body mass index, age and gender. Our results showed that the patients who had CPAP treatment achieved a larger weight reduction than non-CPAP treatment patients in a 16-week intensive calorie restriction weight loss program. Sleep quality may impact success in weight loss programs and several mechanisms may underpin this. Reference: (1) Varady KA. Intermittent versus daily calorie restriction: Which diet regimen is more effective for weight loss? Obes Rev. 2011;12:e593-e601.

Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea

Impact of long-term continuous positive airway pressure on liver fat in male obstructive sleep apnea patients with fatty liver

Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials

Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children

Association between non-alcoholic fatty liver disease and obstructive sleep apnea

Impact of Continuous Positive Airway Pressure Treatment on Left Ventricular Ejection Fraction in Patients with Obstructive Sleep Apnea: a Meta-Analysis of Randomized Controlled Trials.

Effect of Continuous Positive Airway Pressure on Lipid Profiles in Obstructive Sleep Apnea: A Meta-Analysis

Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment

Effect of Continuous Positive Airway Pressure on Lipid Profile in Patients with Obstructive Sleep Apnea Syndrome: a Meta-Analysis of Randomized Controlled Trials.

Changes of Circulating Biomarkers of Inflammation and Glycolipid Metabolism by CPAP in OSA Patients: a Meta-Analysis of Time-Dependent Profiles

Influence of Continuous Positive Airway Pressure Treatment on Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

The impact of obstructive sleep apnea on nonalcoholic fatty liver disease

Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis

Effect of obstructive sleep apnea syndrome on the severity of nonalcoholic fatty liver disease in patients with obesity

SAT-095 the Impact of CPAP on Intensive Calorie Restriction Weight Loss

0560 CPAP Effect on Energy Expenditure, Intake, Body Composition, and Sleep Patterns: A Randomized Controlled Trial

Effect of Continuous Positive Pressure Ventilation on Left Ventricular Diastolic Function E/A Ratio in Patients with Obstructive Sleep Apnea: a Meta-Analysis

Effect of Continuous Positive Airway Pressure on Leptin Levels in Patients with Obstructive Sleep Apnea: A Meta-analysis

CPAP, Weight Loss, or Both for Obstructive Sleep Apnea

Effect of Continuous Positive Airway Pressure on Leptin Levels in Patients with Obstructive Sleep Apnea

[Impact of Long-Term Continuous Positive Airway Pressure Treatment for Patients with Obstructive Sleep Apnea Syndrome].